Lifecare AS will present Q4 2023 financial and operational status in a webcast
Tuesday 27 February. The webcast will be for all shareholders and interested
parties at 12:00 -- 12:45 CET.
Lifecare's CEO Joacim Holter presents the company's Q4 report followed by a
Q&A session where Holter will answer questions submitted in advance. Questions
in connection with the Q4 report can be sent to the e-mail addresses listed
below. Unfortunately, we must take the liberty of moderating the number of
questions due to time constraints.
The webcast will be available here:
Join the Microsoft TEAMS meeting
(https://teams.microsoft.com/l/meetup-join/19%3ameeting_MzU4Zjk1NTMtMGNlMS00ODMwLTk1N2QtYmRhMzAyNDVhNjFj%40thread.v2/0?context={"Tid"%3a"c5fbb1c6-4eb0-45db-9f3c-6e20ebcd710e"%2c"Oid"%3a"71082610-7009-40ed-92e6-70ae6bc35450"})
https://teams.microsoft.com/l/meetup-join/19%3ameeting_MzU4Zjk1NTMtMGNlMS00ODMwLTk1N2QtYmRhMzAyNDVhNjFj%40thread.v2/0?context=%7b%22Tid%22%3a%22c5fbb1c6-4eb0-45db-9f3c-6e20ebcd710e%22%2c%22Oid%22%3a%2271082610-7009-40ed-92e6-70ae6bc35450%22%7d
About us
Lifecare AS is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market. Lifecare enables osmotic pressure as sensing principle, combined
with the ability to manipulate Nano-granular Tunnelling Resistive sensors
("NTR") on the sensor body for read-out of pressure variations. Lifecare's
sensor technology is referred to as "Sencell" and is suitable for identifying
and monitoring the occurrence of a wide range of analytes and molecules in the
human body.
Contacts
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40
Asle Wingsternes, Head of Communications & Public Affairs,
asle.wingsternes@lifecare.no, +47 41 61 42 52